References
- Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. : Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 : 756-760, 2006 https://doi.org/10.1038/nature05236
- Bowman RL, Wang Q, Carro A, Verhaak RG, Squatrito M : GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neuro Oncol 19 : 139-141, 2017 https://doi.org/10.1093/neuonc/now247
- Conduit PT, Wainman A, Raff JW : Centrosome function and assembly in animal cells. Nat Rev Mol Cell Biol 16 : 611-624, 2015 https://doi.org/10.1038/nrm4062
- Dai J, Bing Z, Zhang Y, Li Q, Niu L, Liang W, et al. : Integrated mRNAseq and microRNAseq data analysis for grade III gliomas. Mol Med Rep 16 : 7468-7478, 2017 https://doi.org/10.3892/mmr.2017.7545
- Diwanji TP, Engelman A, Snider JW, Mohindra P : Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults. Adolesc Health Med Ther 8 : 99-113, 2017 https://doi.org/10.2147/AHMT.S53391
- Dong W, Li H, Zhang Y, Yang H, Guo M, Li L, et al. : Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer. Acta Biochim Biophys Sin (Shanghai) 43 : 840-848, 2011 https://doi.org/10.1093/abbs/gmr085
- Fu X, Zhu Y, Zheng B, Zou Y, Wang C, Wu P, et al. : KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma. Int J Oncol 52 : 1912-1922, 2018
- Global Burden of Disease Cancer Collaboration; Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. : Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3 : 524-548, 2017 https://doi.org/10.1001/jamaoncol.2016.5688
- Grinberg-Rashi H, Ofek E, Perelman M, Skarda J, Yaron P, Hajduch M, et al. : The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res 15 : 1755-1761, 2009 https://doi.org/10.1158/1078-0432.CCR-08-2124
- Han J, Wang F, Lan Y, Wang J, Nie C, Liang Y, et al. : KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling. Oncogene 38 : 406-420, 2019 https://doi.org/10.1038/s41388-018-0440-8
- Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, et al. : Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res 11 : 5084-5089, 2005 https://doi.org/10.1158/1078-0432.CCR-05-0200
- Kleylein-Sohn J, Pollinger B, Ohmer M, Hofmann F, Nigg EA, Hemmings BA, et al. : Acentrosomal spindle organization renders cancer cells dependent on the kinesin HSET. J Cell Sci 125(Pt 22) : 5391-5402, 2012
- Klionsky DJ : Autophagy revisited: a conversation with Christian de Duve. Autophagy 4 : 740-743, 2008 https://doi.org/10.4161/auto.6398
- Levine MS, Bakker B, Boeckx B, Moyett J, Lu J, Vitre B, et al. : Centrosome amplification is sufficient to promote spontaneous tumorigenesis in mammals. Dev Cell 40 : 313-322.e5, 2017 https://doi.org/10.1016/j.devcel.2016.12.022
- Li Y, Lu W, Chen D, Boohaker RJ, Zhai L, Padmalayam I, et al. : KIFC1 is a novel potential therapeutic target for breast cancer. Cancer Biol Ther 16 : 1316-1322, 2015 https://doi.org/10.1080/15384047.2015.1070980
- Liu Y, Pelletier L : A magic bullet for targeting cancers with supernumerary centrosomes. EMBO J 38 : e101134, 2019
- Liu Y, Zhan P, Zhou Z, Xing Z, Zhu S, Ma C, et al. : The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer. J Thorac Dis 8 : 2911-2923, 2016 https://doi.org/10.21037/jtd.2016.10.67
- Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. : The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 : 97-109, 2007 https://doi.org/10.1007/s00401-007-0243-4
- Mittal K, Choi DH, Klimov S, Pawar S, Kaur R, Mitra AK, et al. : A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas. J Ovarian Res 9 : 17, 2016
- Pallichankandy S, Rahman A, Thayyullathil F, Galadari S : ROS-dependent activation of autophagy is a critical mechanism for the induction of anti-glioma effect of sanguinarine. Free Radic Biol Med 89 : 708-720, 2015 https://doi.org/10.1016/j.freeradbiomed.2015.10.404
- Pawar S, Donthamsetty S, Pannu V, Rida P, Ogden A, Bowen N, et al. : KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries. J Ovarian Res 7 : 53, 2014
- Rath O, Kozielski F : Kinesins and cancer. Nat Rev Cancer 12 : 527-539, 2012 https://doi.org/10.1038/nrc3310
- Sekino Y, Oue N, Koike Y, Shigematsu Y, Sakamoto N, Sentani K, et al. : KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer. J Clin Med 8 : 225, 2019
- Sekino Y, Oue N, Shigematsu Y, Ishikawa A, Sakamoto N, Sentani K, et al. : KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer. Urol Oncol 35 : 31.e13-31.e20, 2017
- Shin SY, Lee KS, Choi YK, Lim HJ, Lee HG, Lim Y, et al. : The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells. Carcinogenesis 34 : 2080-2089, 2013 https://doi.org/10.1093/carcin/bgt169
- Tang Z, Kang B, Li C, Chen T, Zhang Z : GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47(W1) : W556-W560, 2019 https://doi.org/10.1093/nar/gkz430
- Teng K, Wei S, Zhang C, Chen J, Chen J, Xiao K, et al. : KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity. J Exp Clin Cancer Res 38 : 329, 2019
- Webb AH, Gao BT, Goldsmith ZK, Irvine AS, Saleh N, Lee RP, et al. : Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. BMC Cancer 17 : 434, 2017
- Wen ZP, Zeng WJ, Chen YH, Li H, Wang JY, Cheng Q, et al. : Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux. J Exp Clin Cancer Res 38 : 298, 2019
- Xiao KH, Teng K, Ye YL, Tan L, Chen MK, Liang HT, et al. : Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling. Cancer Sci 110 : 2822-2833, 2019 https://doi.org/10.1111/cas.14126
- Xiao YX, Yang WX : KIFC1: a promising chemotherapy target for cancer treatment? Oncotarget 7 : 48656-48670, 2016 https://doi.org/10.18632/oncotarget.8799
- Yu Y, Feng YM : The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy. Cancer 116 : 5150-5160, 2010 https://doi.org/10.1002/cncr.25461
- Zhang H, Ma Y, Wang H, Xu L, Yu Y : MMP-2 expression and correlation with pathology and MRI of glioma. Oncol Lett 17 : 1826-1832, 2019 https://doi.org/10.3892/ol.2018.9806
- Zhou K, Zhao J, Qi L, He Y, Xu J, Dai M : Kinesin family member C1 (KIFC1) accelerates proliferation and invasion of endometrial cancer cells through modulating the PI3K/AKT signaling pathway. Technol Cancer Res Treat 19 : 1533033820964217, 2020